Omada Health closed at $18.95 on Nov 5, down 2.47%, 25.3% below its 52-week closing high. Volume of 2.0M shares was 2.03× its 20-day average (well above normal).
Split-adjusted performance: -9.3% over one month, +15.5% over six months, -25.3% over one year.
In the quarter ended Jun 30, 2026, revenue was $87.83M, up 43.1% from a year earlier, with a net margin of 6.0%.
Short interest was 8.3M shares at the Oct 15 settlement, up 12.0% from the prior report (20.6% of float, 6.7 days to cover).